Joseph Swiader

Joseph Swiader

Biography
  • CEO, Nonpareil Biotechnologies
Print Friendly
  • Joseph is an biotechnology investor and entrepreneur with 24 years of experience in the biotechnology, pharmaceuticals and medical technology industries.  Beginning his investment career as a biotechnology analyst at JP Morgan Securities, Joseph was later a bio-pharmaceutical analyst at The Dreyfus Corporation, Scudder Investments and Feirstein Capital Management.
  • Most recently in late 2015, Joseph founded Nonpareil Biotechnologies, a biotechnology accelerator that translates early research into new innovative drug therapies and develops biosignature analytic technologies.
  • During his career, Joseph has invested over $30 billion of institutional capital and helped scores of innovative companies by providing capital, research and development strategies, business development strategies, strategic consulting and board membership.
  • Joseph received a BS from Babson College in finance and entrepreneurial studies in 1992.